Enter inventor name

EPO Patents = 1

Average Co-Inventor Count = 6.1

ph-index = 6

Forward Citations = 107(Granted Patents)

Location History:

Burlingame, CA (US) (2010)
San Bruno, CA (US) (2012)
South San Francisco, CA (US) (2015 - 2019)
Foster City, CA (US) (2003 - 2021)

Company Filing History:

Xenon Pharmaceuticals Inc.

F. Hoffmann-la Roche Ag

patents

6. 1 out of 623

Silicon Storage Technology, Inc.

patents

7. 1 out of 1

Hoffman-laroche, Inc. (us Only)

patent

8. 1 out of 1

F. Hoffman-laroche, Ag (ex-us)

patent

where one patent can have more than one assignee

Years Active: 2003-2021

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10966963 - Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof (2021-04-06),

2. 10654867 - Heteroaryl estrogen receptor modulators and uses thereof (2020-05-19),

3. 10179767 - Substituted benzamides and methods of use thereof (2019-01-15),

4. 9980947 - Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof (2018-05-29),

5. 9694002 - Substituted benzamides and methods of use thereof (2017-07-04),

6. 9546164 - Substituted benzamides and methods of use thereof (2017-01-17),

7. 8952169 - N-substituted benzamides and methods of use thereof (2015-02-10),

8. 8846681 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2014-09-30),

9. 8293736 - Purine compounds selective for PI3K P110 delta, and methods of use (2012-10-23),

10. 8003651 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2011-08-23),

11. 7749994 - Pentacyclic kinase inhibitors (2010-07-06),

12. 6548995 - High speed bias voltage generating circuit (2003-04-15),

Title: The Innovative Contributions of Jun M Li

Introduction

Jun M Li, an inventive mind based in Burlingame, California, has made significant strides in the field of pharmaceutical research and development. With a portfolio of 12 patents, his work primarily focuses on estrogen receptor modulators, which hold potential for addressing various health conditions.

Latest Patents

Among his latest innovations, Jun M Li has developed patents for "Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof." This patent describes tetrahydro-pyrido[3,4-b]indol-1-yl compounds exhibiting estrogen receptor modulation, characterized by a specific structural formula. The compounds are accompanied by descriptions of pharmaceutical compositions, methods of use, and combinations with other therapeutic agents for treating estrogen-dependent diseases. Additionally, his work on "Heteroaryl estrogen receptor modulators and uses thereof" highlights the modulation activity of heteroaryl compounds through specific molecular structures.

Career Highlights

Jun M Li has been an integral part of leading pharmaceutical companies, including Genentech, Inc. and Xenon Pharmaceuticals Inc. His experience in these organizations has contributed to his expertise in drug development and innovation in therapeutic solutions.

Collaborations

Throughout his career, Jun has collaborated with notable professionals, including Brian Salvatore Safina and Daniel Fred Ortwine. These partnerships have likely enriched his research endeavors and have fostered a collaborative approach in developing groundbreaking technologies.

Conclusion

Jun M Li stands out as an inventor whose contributions help advance medical science. His patents not only reflect his innovative spirit but also hold promise for future therapies aimed at improving health outcomes through sophisticated estrogen modulation. His journey in the pharmaceutical landscape continues to inspire new innovative paths.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com